Date published: 2026-5-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

2810485I05Rik Activators

Protein 2810485I05Rik activators encompass a spectrum of chemical compounds that, through diverse molecular mechanisms, enhance the functional activity of the protein. Forskolin and IBMX both elevate intracellular levels of cAMP, a secondary messenger thatGiven that you've provided the gene name 2810485I05Rik without a corresponding protein name, I will assume that 2810485I05Rik is the gene name and the protein name has been omitted. The chemical class identified as 2810485I05Rik Activators comprises compounds that can upregulate the expression of the gene encoded by the 2810485I05Rik locus. To pinpoint activators within this group, a comprehensive and detailed approach is employed, starting with high-throughput screening (HTS). This technique allows for the rapid and efficient assessment of a vast array of chemical compounds to discern their ability to modulate gene activity. The cornerstone of HTS in this context is the reporter gene assay, a system ingeniously designed to signal the activation of the 2810485I05Rik gene. Within this assay, a reporter gene that typically codes for a protein capable of generating a quantifiable signal, such as luminescence or fluorescence, is placed under the control of the 2810485I05Rik promoter. When a chemical compound interacts with this promoter, it induces the expression of the reporter gene, which results in a measurable output. The intensity of this output directly reflects the compound's ability to stimulate gene expression. Compounds that can cause a marked increase in reporter activity are carefully selected for further investigation. This initial screening is critical as it identifies compounds that can specifically target and boost the function of the 2810485I05Rik gene from a broad spectrum of chemical substances. Following the high-throughput screening process, compounds classified as potential 2810485I05Rik Activators undergo a rigorous validation sequence to confirm their gene activation capabilities. This process begins with quantitative polymerase chain reaction (qPCR) analysis, a highly sensitive technique that quantifies the mRNA output of the 2810485I05Rik gene after interaction with the compounds. An increase in mRNA levels, when compared to baseline expression, indicates that the compound can stimulate the gene's transcription.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-selective inhibitor of phosphodiesterases, enzymes that degrade cAMP. By preventing cAMP degradation, IBMX increases intracellular cAMP levels, which can indirectly enhance Protein 2810485I05Rik activity through cAMP-dependent pathways.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

This catechin inhibits several protein kinases, altering various signaling cascades. By inhibiting competitive pathways, Epigallocatechin gallate may enhance signaling pathways that promote the activation of Protein 2810485I05Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which leads to a reduction in Akt phosphorylation and activity. This alteration in the PI3K/Akt pathway can result in the activation of downstream targets that may include Protein 2810485I05Rik.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an MEK inhibitor, which can lead to reduced ERK activation. This shift in MAPK signaling dynamics could indirectly enhance the activity of Protein 2810485I05Rik if it is part of a pathway that is negatively regulated by ERK.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

AICAR activates AMPK, which is a sensor of cellular energy status. Activation of AMPK can lead to enhanced activity of Protein 2810485I05Rik if it is regulated by energy status or involved in metabolic signaling pathways.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a PKC activator, leading to the activation of protein kinase C isoforms. PKC activation can enhance pathways that lead to the activation of Protein 2810485I05Rik if it is downstream of PKC.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor, which may alter the balance of cell signaling pathways. By inhibiting p38 MAPK, SB203580 could indirectly enhance the activation of Protein 2810485I05Rik through interconnected signaling networks.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a ROCK inhibitor, which can lead to changes in the actin cytoskeleton. This can influence signaling pathways that indirectly activate Protein 2810485I05Rik, especially if it is associated with cytoskeletal dynamics.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which is involved in cell growth and proliferation. Inhibition of mTOR can lead to the activation of compensatory pathways that may include the activation of Protein 2810485I05Rik.